Q3 25 EPS
$1.14
MISS 2.16%
Est. $1.17
Q3 25 Revenue
$2.20B
MISS 3.23%
Est. $2.28B
vs S&P Since Q3 25
+9.6%
BEATING MARKET
EMN +20.8% vs S&P +11.2%
Market Reaction
Did EMN Beat Earnings? Q3 2025 Results
Eastman Chemical delivered a disappointing third quarter, missing on both the top and bottom lines as weakening consumer demand and an unusual inventory unwind weighed heavily on results. Adjusted EPS came in at $1.14, falling short of the $1.17 cons… Read more Eastman Chemical delivered a disappointing third quarter, missing on both the top and bottom lines as weakening consumer demand and an unusual inventory unwind weighed heavily on results. Adjusted EPS came in at $1.14, falling short of the $1.17 consensus estimate by 2.16%, while revenue dropped 10.6% year-over-year to $2.20 billion, trailing analyst expectations of $2.28 billion by 3.23%. The primary culprit was a customer-driven destocking cycle, as buyers unwound tariff-related inventory prepositioned in the first half of the year, compressing volumes across all four operating segments and forcing aggressive inventory reduction actions that weighed on asset utilization. Fibers bore the sharpest pain, with revenue down 24% on acetate tow destocking and softer China textiles demand, while Chemical Intermediates fell 16% on weak building and construction activity. Despite the shortfall, management maintained full-year 2025 adjusted EPS guidance of $5.40 to $5.65 with operating cash flow approaching $1.00 billion, underpinned by more than $75.00 million in targeted net cost savings, though analysts have trimmed price targets following the softer outlook.
Key Takeaways
- • Weakness in consumer discretionary end markets including building and construction, consumer durables, and auto aftermarket
- • Customer unwinding of tariff-related inventory prepositioned in first half of 2025
- • Aggressive inventory management actions driving approximately $200 million inventory reduction from Q2 levels
- • Substantially lower asset utilization to drive cash generation
- • Competitive spread compression in Chemical Intermediates
- • Commercial excellence in defending prices and market share across specialty businesses
- • Cost structure reduction actions partially offsetting volume headwinds
EMN YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
EMN Revenue by Segment
With YoY comparisons, source: SEC Filings
EMN Revenue by Geography
With YoY comparisons, source: SEC Filings
“Our third-quarter financial results reflect the actions we took to reduce inventory and prioritize cash generation. With the weak macroeconomic environment persisting, our focus on cash generation, disciplined capital allocation, and structural cost reduction is more important than ever. As expected, in the third quarter we realized a slowdown in orders due to normal seasonality and customers unwinding inventory that was prepositioned to avoid tariff risk in a weakening consumer environment. In this context, our teams demonstrated continued commercial excellence in defending both prices and market share. We also made good progress on securing Renew rPET contracts for a significant ramp up in sales volume next year. We are taking a number of actions expected to create earnings growth next year and position the company for a strong recovery when the economy stabilizes.”
— Mark Costa, Q3 2025 Earnings Press Release
EMN Earnings Trends
EMN vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
EMN EPS Trend
Earnings per share: estimate vs actual
EMN Revenue Trend
Quarterly revenue: estimate vs actual
EMN Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.06 | $1.09 | +2.42% | $2.18B | -0.06% |
| Q4 25 BEAT FY | $0.72 | $0.75 | +4.15% | $1.97B | -2.09% |
| FY Full Year | $5.39 | $5.42 | +0.63% | $8.75B | -0.42% |
| Q3 25 MISS | $1.17 | $1.14 | -2.16% | $2.20B | -3.23% |
| Q2 25 MISS | $1.75 | $1.60 | -8.71% | $2.29B | -0.75% |
| Q1 25 BEAT | $1.89 | $1.91 | +1.22% | $2.29B | -1.72% |